2-(Chloromethyl)-5-(trifluoromethyl)pyridine hydrochloride, 95.0%, 1g

1-(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole>98.0%(GC)(T)200mg

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid xhydrochloride, 98.0%, 100g

Methyl 1-((4-fluorophenyl)carbamoyl)cyclopropanecarboxylate, 97.0%, 250mg

5-Bromo-4-chloro-2-fluorobenzoic acid, 95.0%, 250mg

Ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate, 95.0%, 5g

3-[4-(propan-2-yl)phenyl]-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

(R)-2-(PIPERIDIN-3-YL)ACETIC ACID HCL, 97.0%, 500mg

4-Bromonicotinic acid, 98.0%, 1g

Feuille de molybdène 99,9+% 0,25 x 150 x 150 mm 1 pièce

(5-phenyl-4H-1,2,4-triazol-3-yl)acetic acid dihydrate, 95.0%, 1g

3,5-Dimethylisoxazole, 99.0%, 100g

3-Chloro-pyrazine-2-carboxylic acid ethyl ester, 95.0%, 5g